← Open Payments lookup

AL FEBRE: Open Payments

NPI 1275834418 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$863 in 36 payments from 12 companies in 2025. Trend: 2023 $914 · 2024 $630 · 2025 $863

Food & beverage: $863
CompanyPaymentsAmount
Janssen Biotech, Inc.3$177
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$156
Gilead Sciences, Inc.1$114
Madrigal Pharmaceuticals4$101
Ipsen Biopharmaceuticals, Inc4$93
ABBVIE INC.4$67
Celltrion USA Inc.3$54
Ardelyx, Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.1$21
Regeneron Healthcare Solutions, Inc.1$16

Products named: TREMFYA, Livdelzi, REZDIFFRA, TRULANCE, IQIRVO, SKYRIZI, RELISTOR, VEGZELMA.

Industry payments across FL — which companies pay providers there.